OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Chalcones reloaded: an integration of network pharmacology and molecular docking for type 2 diabetes therapy
Sarvesh Sabarathinam, Nila Ganamurali
Journal of Biomolecular Structure and Dynamics (2023) Vol. 42, Iss. 18, pp. 9505-9517
Closed Access | Times Cited: 13
Sarvesh Sabarathinam, Nila Ganamurali
Journal of Biomolecular Structure and Dynamics (2023) Vol. 42, Iss. 18, pp. 9505-9517
Closed Access | Times Cited: 13
Showing 13 citing articles:
GC-MS analysis of an ethanolic extract of Ocimum species: a network pharmacology analysis insight towards obesity
Priyadharshini Gnanamurthy, Manoj Kumar Narasimhan, Sarvesh Sabarathinam
Future Science OA (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 6
Priyadharshini Gnanamurthy, Manoj Kumar Narasimhan, Sarvesh Sabarathinam
Future Science OA (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 6
Gut Microbiome-Derived Metabolites and Their Impact on Gene Regulatory Networks in Gestational Diabetes
Sarvesh Sabarathinam, Akash Jayaraman, Ramesh Venkatachalapathy
The Journal of Steroid Biochemistry and Molecular Biology (2025), pp. 106674-106674
Closed Access
Sarvesh Sabarathinam, Akash Jayaraman, Ramesh Venkatachalapathy
The Journal of Steroid Biochemistry and Molecular Biology (2025), pp. 106674-106674
Closed Access
Deciphering the gut microbiota's (Coprococcus and Subdoligranulum) impact on depression: Network pharmacology and molecular dynamics simulation
Sarvesh Sabarathinam
Pharmacology Biochemistry and Behavior (2024) Vol. 241, pp. 173805-173805
Closed Access | Times Cited: 5
Sarvesh Sabarathinam
Pharmacology Biochemistry and Behavior (2024) Vol. 241, pp. 173805-173805
Closed Access | Times Cited: 5
Isolation of 6-gingerol and semi-synthesis of 1,4-benzodiazepines derivatives: An in-situ pharmacokinetics properties, molecular docking and molecular dynamics simulation assessments
Mariyappan Vaithiyalingam, Ramasamy Mohan Kumar, Prerna Khagar, et al.
Saudi Journal of Biological Sciences (2024) Vol. 31, Iss. 8, pp. 104048-104048
Open Access | Times Cited: 4
Mariyappan Vaithiyalingam, Ramasamy Mohan Kumar, Prerna Khagar, et al.
Saudi Journal of Biological Sciences (2024) Vol. 31, Iss. 8, pp. 104048-104048
Open Access | Times Cited: 4
Unlocking the potential of luteolin: A natural migraine management approach through network pharmacology
Rapuru Rushendran, Chitra Vellapandian
Journal of Traditional and Complementary Medicine (2024) Vol. 14, Iss. 6, pp. 611-621
Open Access | Times Cited: 1
Rapuru Rushendran, Chitra Vellapandian
Journal of Traditional and Complementary Medicine (2024) Vol. 14, Iss. 6, pp. 611-621
Open Access | Times Cited: 1
Computational exploration of Ganoderma lucidum metabolites as potential anti-atherosclerotic agents: Insights from molecular docking and dynamics simulations
Sarvesh Sabarathinam, Akash Jayaraman, Ramesh Venkatachalapathy
Computational Biology and Chemistry (2024) Vol. 112, pp. 108160-108160
Closed Access | Times Cited: 1
Sarvesh Sabarathinam, Akash Jayaraman, Ramesh Venkatachalapathy
Computational Biology and Chemistry (2024) Vol. 112, pp. 108160-108160
Closed Access | Times Cited: 1
Synthesis of Quercetin–Iron (Fe) Complex and Its In Silico and In Vitro Confirmation Towards Antibacterial Activity
Prerna Khagar, Atul V. Wankhade, Sarvesh Sabarathinam
Future Medicinal Chemistry (2023) Vol. 15, Iss. 19, pp. 1743-1756
Closed Access | Times Cited: 3
Prerna Khagar, Atul V. Wankhade, Sarvesh Sabarathinam
Future Medicinal Chemistry (2023) Vol. 15, Iss. 19, pp. 1743-1756
Closed Access | Times Cited: 3
Pharmacokinetic Correlation of Structurally Modified Chalcone Derivatives As Promising Leads to Treat Tuberculosis
Sarvesh Sabarathinam, Nila Ganamurali, Sanjana Satheesh, et al.
Future Medicinal Chemistry (2023) Vol. 15, Iss. 20, pp. 1903-1913
Closed Access | Times Cited: 3
Sarvesh Sabarathinam, Nila Ganamurali, Sanjana Satheesh, et al.
Future Medicinal Chemistry (2023) Vol. 15, Iss. 20, pp. 1903-1913
Closed Access | Times Cited: 3
Pharmacological network study on the effect of 6-gingerol on cervical cancer using computerized databases
Fernando Martínez‐Esquivias, Juan Manuel Guzmán‐Flores, Ismael Fernando Chávez-Díaz, et al.
Journal of Biomolecular Structure and Dynamics (2023) Vol. 42, Iss. 21, pp. 11750-11761
Closed Access | Times Cited: 2
Fernando Martínez‐Esquivias, Juan Manuel Guzmán‐Flores, Ismael Fernando Chávez-Díaz, et al.
Journal of Biomolecular Structure and Dynamics (2023) Vol. 42, Iss. 21, pp. 11750-11761
Closed Access | Times Cited: 2
Effect of amikacin-humic acid combination on Acinetobacter baumannii biofilm: an in vitro and in silico study
Seetha Lakshmi Rajangam, K.V. Leela, Manonmoney Jayaraman, et al.
Future Microbiology (2024) Vol. 19, Iss. 18, pp. 1573-1585
Closed Access
Seetha Lakshmi Rajangam, K.V. Leela, Manonmoney Jayaraman, et al.
Future Microbiology (2024) Vol. 19, Iss. 18, pp. 1573-1585
Closed Access
Targeting urotensin II with silymarin: potential therapeutic strategies for diabetes and associated cardiovascular complications
Sarvesh Sabarathinam
Phytochemistry Reviews (2024)
Closed Access
Sarvesh Sabarathinam
Phytochemistry Reviews (2024)
Closed Access
Metformin's modulation of gut microbiota and its implications for non-alcoholic fatty liver disease: A network pharmacology and molecular dynamics study
Sarvesh Sabarathinam, Ramesh Venkatachalapathy, Akash Jayaraman
Human Gene (2024), pp. 201364-201364
Closed Access
Sarvesh Sabarathinam, Ramesh Venkatachalapathy, Akash Jayaraman
Human Gene (2024), pp. 201364-201364
Closed Access
Unveiling the therapeutic potential of quercetin and its metabolite (Q3OG) for targeting inflammatory pathways in Crohn's disease: A network pharmacology and molecular dynamics approach
Sarvesh Sabarathinam
Human Gene (2024), pp. 201372-201372
Closed Access
Sarvesh Sabarathinam
Human Gene (2024), pp. 201372-201372
Closed Access